Cisen Pharmaceutical Co Ltd (603367) — Capital Reinvestment Ratio

Latest as of September 2025: 0.08x

Cisen Pharmaceutical Co Ltd (603367) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥311.93 Million) in capital expenditures (CN¥25.75 Million). See net asset quality index of Cisen Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥311.93 Million
CNY

Capital Expenditures

CN¥25.75 Million
CNY

Data as of

Sep 2025
Most recent filing

Cisen Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)

This chart tracks Cisen Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 14 annual periods. Check cash flow reinvestment rate of Cisen Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Cisen Pharmaceutical Co Ltd (2011–2024)

Year-by-year Capital Reinvestment Ratio for Cisen Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see Cisen Pharmaceutical Co Ltd market cap and net worth.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 0.18x CN¥570.85 Million CN¥101.81 Million ▲ +354.4%
2023 0.04x CN¥451.24 Million CN¥17.71 Million ▼ -71.2%
2022 0.14x CN¥258.35 Million CN¥35.19 Million ▼ -37.6%
2021 0.22x CN¥233.60 Million CN¥51.02 Million ▼ -53.5%
2020 0.47x CN¥431.01 Million CN¥202.27 Million ▼ -17.7%
2019 0.57x CN¥181.26 Million CN¥103.37 Million ▲ +474.7%
2018 0.10x CN¥406.68 Million CN¥40.36 Million ▲ +81.9%
2017 0.05x CN¥439.61 Million CN¥23.98 Million ▼ -62.5%
2016 0.15x CN¥291.97 Million CN¥42.45 Million ▲ +102.8%
2015 0.07x CN¥266.24 Million CN¥19.09 Million ▼ -95.9%
2014 1.77x CN¥27.54 Million CN¥48.68 Million ▼ -36.1%
2013 2.77x CN¥81.26 Million CN¥224.88 Million ▲ +217.4%
2012 0.87x CN¥33.09 Million CN¥28.85 Million ▼ -49.1%
2011 1.71x CN¥76.28 Million CN¥130.58 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow